Researchers say the experimental drug produced close to three times the weight loss of current options over the same stretch of time.
Recap by typeshit. Full story at Women's Health on MSN.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
27:27
Becky Reynolds covers her three-month update on oral Wegovy, with food hauls and how she handled eating on a cruise.
A short social post on the body changes that can follow rapid weight loss on Ozempic and Wegovy, including the much discussed Ozempic face.
Loading…